FDA recall, , Low risk
Unichem Doxazosin Tablets
Doxazosin Tablets, USP, 4 mg are imprinted with the wrong ID.
Summary by Recall Canary from the FDA notice
What happened
Unichem Pharmaceuticals USA Inc., of East Brunswick, New Jersey, recalled Doxazosin Tablets, USP, 4 mg, 1000 tablets per bottle, distributed nationwide, because the tablets are imprinted with the wrong ID. The recall began on January 21, 2026, and was added to the FDA's Enforcement Report on February 11, 2026. The affected product is manufactured by Unichem Laboratories Limited in Goa, India.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Doxazosin Tablets, USP, 4 mg
- NDC
- 29300-353-10
- Lot code
- GDSH25006
Recall details
- Company began the recall
- Sold in
- Nationwide
- Company
- Unichem Pharmaceuticals USA Inc.East Brunswick, New Jersey
- Hazard
- Labeling error
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 98321
- Recall number
- D-0306-2026
- Quantity recalled
- 60,000 tablets
All recalls from Unichem Pharmaceuticals USA Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
In FDA's weekly enforcement report
Listed on Recall Canary
Summary updated
